2020
DOI: 10.17352/ojpdt.000008
|View full text |Cite
|
Sign up to set email alerts
|

Parkon® in the treatment of multiple sclerosis. A pilot study

Abstract: other exogenous ROS activate aerobic metabolism and induce macrophage activation. This includes the previously established non-specifi c stimulation of the endogenous interferon system by ROS-activated macrophages [4], which may have a special place in the clinical effects of Parkon.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 10 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?